Ectodermal dysplasia (ED) is an inherited disorder that affects two or more ectodermal derivatives. This includes hair, teeth, nails, sweat glands and skin.1,2
There is conflicting evidence on the prevalence of ED, but the National Foundation for Ectodermal Dysplasia (NFED) suggests that around 14.5 per 100,000 people will be affected by ED. ED is classified as a rare condition, and due to its rarity, it makes it harder to study.3 The most common variant of EDs is known as hypothyroid ED, which is commonly X-linked and is only seen in males. Hypohidrotic EDs present with hair and tooth anomalies, as well as an inability to sweat. One reason why it is hard to determine the prevalence of ED is due to different case definitions, as some studies base their numbers on clinically suspected ED (clinical symptoms or signs of the condition), whilst others require molecular confirmation. Studies which rely on molecularly confirmed cases often result in lower numbers of confirmed cases.4
Classification
Syndromic EDs refer to EDs which relate to a broader syndrome that involves non-ectodermal systems or additional malformations such as a cleft lip. Non-syndromic EDs are isolated ectodermal involvement, with no or minimal non-ectodermal features.
Traditional classification is based on which of the primary ectodermal structures is affected. This is known as the 1-2-3-4 system. Hair1 nails2 teeth3 and sweat glands.4 Syndromes EDs will often involve multiple structures, whereas non-syndromes EDs may only involve one structure. However, this system only considered four structures, and does not account fr extra-ectodermal features and does not account for genetic or molecular information. Therefore, in 2017, a new classification system emerged that classified EDs along three axes. Phenotype, which describes the structures affected. Genotype, which identifies the exact genes mutated. Molecular pathway which groups conditions by the signalling pathways that were disrupted. This new system allows for recognition that syndromic and non-syndromic forms may lie on a spectrum of the same genetic disorder. It also facilitated new research, diagnosis and genetic counselling. Phenotypic comparison
Syndromic ED phenotypes typically include features such as hypohidrosis/anhidrosis (reduced or absent sweating) due to lacking or dysfunctional sweat glands.5 This can lead to heat intolerance as well as put the patient at risk of heat stroke. Sparse hair is found in many ED syndromes, such as Clouston syndrome, and can cause psychosocial distress. Conical or missing teeth can impact mastication or lead to speech issues. It is common in most syndromic EDs. Nail dystrophy is when the nails are abnormally shaped, thickened or ridged. It can affect both hands and feet and is most common in Clouston syndrome. Skin anomalies such as thin or dry skin can lead to rashes or thickening of the soles. Again, this is commonly seen in Clouston syndrome. Additional features can include ectrodactyly, where one or more of the central fingers or toes are missing or malformed. This is strongly associated with ectrodactyly ectodermal dysplasia clefitng (EEC) syndrome. A cleft palate is sometimes also seen, which can lead to feeding or speech issues. This is seen in Hay-Wells syndrome as well as EEC syndrome. Finally, some ED syndromes can lead to immunodeficiency due to disruption in signalling pathways, leaving patients vulnerable ot recurrent infections. Non-syndromic phenotypes are often restricted to one or more ectodermal derivatives but have few systemic or non-ectodermal anomalies.6 Both syndromic and non-syndromic forms have variable expression, for example, the number of missing teeth or the degree of hair abnormality.
Genetic basis
The most common genes implicated in syndromic EDs are EDA, EDAR (both form part of the EDA-NF-kB signalling axis, which contains the development of ectodermal structures) and TP63 (which has roles in epidermal and limb development). Syndromic EDs are genetically heterogeneous and usually involve genes that play a key role in ectodermal development. Mutations in these genes cause multiple unrelated effects because they affect proteins early on in embryogenesis. This then means that formation of several ectodermal derivatives can be effected. As a result, a single gene defect can present with multiple abnormalities. Non-syndromic EDs genetics is similar to syndromic forms, making it hard to draw a boundary between the two types. Allergic variation of the same gene can lead to the production of different phenotypes, meaning that a certain variant of a gene might lead to non-syndromic EDs. Non-syndromic presentation can also arise from mutations in genes with tissue-restricted roles.
Inheritance patterns in ED are diverse and can include X-linked, as well as dominant and recessive inheritance patterns.
Diagnosis
Diagnosis of EDs relies on recognition of abnormalities in ectodermal derivatives, combined with family history and molecular testing. Syndromic EDs are typically identified when these features occur alongside findings such as cleft palate, limb malformation or immunodeficiency. In comparison non non-syndromic EDs are often limited to single tissues, and therefore these systemic findings will not be seen. Genetic testing, especially a method called next-generation sequencing, makes it easier to distinguish between syndromic and non-syndromic presentations. Different diagnoses are important as clinicians must exclude alternative causes of abnormalities, such as environmental reasons.7
Management and treatment
Approaches to management and treatment share common elements between syndromic and non-syndromic EDs. Both require multidisciplinary care, with dental work, thermorégulations strategies and psychological support being central to improving a patient’s quality of life.8,9 However, they differ in scope as syndromic EDs cover a wider range of areas that need to be targeted. This could include surgeries to repair a cleft palate or orthopaedic care for ectrodactyly. Prognosis reflects this distinction as well, with syndromic EDs carrying a higher medical and psychosocial burden.
Summary
Syndromic and non-syndromic forms of ectodermal dysplasia differ in scope, complexity and clinical burden. However, they exist along a shared spectrum. Syndromic ED tends to be more complex and involves multiple ectodermal derivatives as well as systemic features. Non-syndromic forms are restricted to single or a few tissues such as teeth, hair or nails. They both can arrive from the same core genetic pathways, with allergic variation explaining why some mutations have broader syndromes, and some have isolated traits. Management similarly reflects both its similarities and differences. Syndromic EDs require care for ectodermal structures, but both require support from a multidisciplinary team. For clinicians, accurate recognition, genetic counselling, and long-term support remain essential.
Comparison table
| Syndromic ED | Non-syndromic ED | |
| Number of ectodermal tissues involved | Non-syndromic ED | One or few ectodermal derivatives |
| Genetic complexity | X-linked, autosomal dominant, recessive | More specific genes, milder variants |
| Inheritence | Multiple, plus non-ectodermal features | X-linked, autosomal dominant, recessive |
| Clinical severity and morbidity | Higher, greater risk of complication | Lower, impact more localised |
| Diagnosis difficulty | More obvious but requires multidisciplinary evaluation | Under recognised, mistaken for isolated abnormalities |
| treatment burden | Higher | Lower |
| Prognosis | Greater impact on lie expectancy | Overall, life expectancy is less impacted |
References
- Majmundar VD, Baxi K. Ectodermal Dysplasia [Internet]. Nih.gov. StatPearls Publishing; 2023 [cited 2025 Sep 21]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK563130/
- Wright JT, Fete M, Schneider H, Zinser M, Koster MI, Clarke AJ, et al. Ectodermal dysplasias: Classification and organization by phenotype, genotype and molecular pathway. American Journal of Medical Genetics Part A [Internet]. 2019 Mar 1;179(3):442–7. Available from: https://pubmed.ncbi.nlm.nih.gov/30703280/
- FAQs [Internet]. National Foundation for Ectodermal Dysplasias. 2025. Available from: https://nfed.org/learn/faqs/
- Nguyen-Nielsen M, Skovbo S, Svaneby D, Pedersen L, Fryzek J. The prevalence of X-linked hypohidrotic ectodermal dysplasia (XLHED) in Denmark, 1995-2010. European Journal of Medical Genetics [Internet]. 2013 May 1 [cited 2023 May 15];56(5):236–42. Available from: https://pubmed.ncbi.nlm.nih.gov/23416623/
- Ngan V. Ectodermal dysplasia [Internet]. DermNet®. 2023 [cited 2025 Sep 21]. Available from: https://dermnetnz.org/topics/ectodermal-dysplasia
- Peschel N, J. Timothy Wright, Koster MI, Clarke A, Gianluca Tadini, Fete M, et al. Molecular Pathway-Based Classification of Ectodermal Dysplasias: First Five-Yearly Update. Genes. 2022 Dec 10;13(12):2327–7.
- Deshmukh S, Prashanth S. Ectodermal Dysplasia: A Genetic Review. International Journal of Clinical Pediatric Dentistry [Internet]. 2012 [cited 2021 May 15];5(3):197–202. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155886/
- Bergendal B. Orodental manifestations in ectodermal dysplasia-A review. American Journal of Medical Genetics Part A. 2014 Apr 9;164(10):2465–71.
- Schneider H. Ectodermal dysplasias: New perspectives on the treatment of so far immedicable genetic disorders. Frontiers in Genetics. 2022 Sep 6;13.

